„Sleep attacks” in Parkinson patients. A side effect of nonergoline dopamine agonists or a class effect of dopamine agonists? - Moller,J.C.; Stiasny,K.; Cassel,W.; Peter,J.H.; Kruger,H.P.; Oertel,W.H. (Nervenarzt, 2000)